Gabriel Lopez-Berestein
Affiliations: | The University of Texas Graduate School of Biomedical Sciences at Houston |
Area:
Molecular Biology, OncologyGoogle:
"Gabriel Lopez-Berestein"Children
Sign in to add trainee
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Joseph R, Dasari SK, Umamaheswaran S, et al. (2024) EphA2- and HDAC-Targeted Combination Therapy in Endometrial Cancer. International Journal of Molecular Sciences. 25 |
| Szymanowski W, Szymanowska A, Bielawska A, et al. (2023) Aptamers as Potential Therapeutic Tools for Ovarian Cancer: Advancements and Challenges. Cancers. 15 |
| Dasari SK, Joseph R, Umamaheswaran S, et al. (2023) Combination of EphA2- and Wee1-Targeted Therapies in Endometrial Cancer. International Journal of Molecular Sciences. 24 |
| Noh K, Bach DH, Choi HJ, et al. (2020) The hidden role of paxillin: localization to nucleus promotes tumor angiogenesis. Oncogene |
| Elsayed AM, Amero P, Salama SA, et al. (2020) Back to the Future: Rethinking the Great Potential of lncRNA for Optimizing Chemotherapeutic Response in Ovarian Cancer. Cancers. 12 |
| Lara OD, Bayraktar E, Amero P, et al. (2020) Therapeutic efficacy of liposomal Grb2 antisense oligodeoxynucleotide (L-Grb2) in preclinical models of ovarian and uterine cancer. Oncotarget. 11: 2819-2833 |
| Miyake TM, Pradeep S, Bayraktar E, et al. (2020) NRG1/ERBB3 pathway activation induces acquired resistance to XPO1 inhibitors. Molecular Cancer Therapeutics |
| Attia YM, Shouman SA, Salama SA, et al. (2020) Blockade of CDK7 Reverses Endocrine Therapy Resistance in Breast Cancer. International Journal of Molecular Sciences. 21 |
| Kanlikilicer P, Bayraktar R, Denizli M, et al. (2020) Corrigendum to 'Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer' [EBioMedicine 38 (2018) 100-112]. Ebiomedicine. 52: 102630 |
| El-Arabey AA, Denizli M, Kanlikilicer P, et al. (2020) GATA3 as a master regulator for interactions of tumor-associated macrophages with high-grade serous ovarian carcinoma. Cellular Signalling. 109539 |